BioSpace News Archive

Two-day, Annual Event Took Place at its Maple Grove, Minnesota Headquarters

LivaNova PLC announced Damien McDonald, Chief Executive Officer, and Thad Huston, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Tuesday, June 4 in New York at 11 a.m. Eastern Time.

credentis, a leader in state-of-the-art oral biology research and development, and DentaQuest, the nation’s leading purpose-driven oral health care organization, have entered into a strategic partnership to test and promote Curodont™ Repair Fluoride Plus and other Curolox® products in the North American Market, enabling better pre-cavity treatment and prevention for US consumers.

Stasior to Lead Build-Out of Data Infrastructure for the Genetic Diagnostic and Therapeutic Technology Company

New research from the Abramson Cancer Center at the University of Pennsylvania, published in the May 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network,

According to a new series of reports by iData Research, the European cardiac surgery device market is valued at $2.7 billion USD, and is expected to grow at a CAGR of 11.5% to reach $4.5 billion by 2024.

New research by Orbis International, Queen’s University Belfast and Wenzhou Medical University has found that offering glaucoma screening in China could be highly cost-effective while reducing blindness among the population.

Today, the U.S. Food and Drug Administration cleared for marketing two tests that can detect the presence of the bacteria Chlamydia trachomatis and Neisseria gonorrhoeae

Families affected by childhood cancer to participate in a unique sleepover at Titletown, neighboring Lambeau Field

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) 510(k) clearance for the cobas® TV/MG test for use on the cobas® 6800/8800 Systems for the detection of Trichomonas vaginalis (TV) and/or Mycoplasma genitalium